Regeneron Pharmaceuticals, Inc.

Rachunek Zysków i Strat


Statystyki
Dywidendy
Rekomendacje
Wyceny
Wskaźniki
Analiza techniczna



Przychody TTM (mln): 13 847
EBIT TTM (mln): 4 362
index 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25
Rok finansowy 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Przychód (mln) 34 59 22 22 57 174 66 63 125 238 379 459 446 1,378 2,105 2,820 4,104 4,860 5,872 6,711 7,863 8,497 16,072 12,173 13,117 14,202
Przychód Δ r/r 0.0% 71.8% -62.9% 0.1% 161.5% 202.7% -62.0% -4.1% 97.1% 90.7% 59.1% 21.0% -2.9% 209.2% 52.7% 34.0% 45.5% 18.4% 20.8% 14.3% 17.2% 8.1% 89.1% -24.3% 7.8% 8.3%
Marża brutto 89.6% 73.7% 70.4% 70.5% 88.4% 91.3% 85.6% 87.2% 100.0% 99.6% 99.6% 99.5% 99.1% 93.9% 92.6% 92.7% 90.4% 93.8% 93.2% 93.5% 90.1% 86.8% 84.8% 87.2% 86.2% 86.1%
EBIT (mln) -24 -25 -86 -122 -100 6 124 -108 -114 -90 -74 -97 -205 458 760 838 1,252 1,331 2,080 2,534 2,210 3,577 8,947 4,739 4,047 3,991
EBIT Δ r/r 0.0% 6.2% 239.0% 42.3% -18.0% -105.6% 2103.7% -186.5% 6.3% -21.5% -17.5% 31.5% 110.5% -323.1% 66.0% 10.3% 49.3% 6.3% 56.3% 21.9% -12.8% 61.9% 150.1% -47.0% -14.6% -1.4%
EBIT (%) -69.0% -42.6% -389.9% -554.6% -173.9% 3.2% 188.0% -169.7% -91.5% -37.7% -19.5% -21.2% -46.0% 33.2% 36.1% 29.7% 30.5% 27.4% 35.4% 37.8% 28.1% 42.1% 55.7% 38.9% 30.9% 28.1%
Koszty finansowe (mln) -1 5 -12 -9 -4 -48 -41 -17 -21 8 2 9 21 45 46 37 14 7 25 28 30 57 57 59 73 55
EBITDA (mln) -21 -16 -92 -123 -92 -27 99 -110 -124 -90 -60 -97 -205 458 760 838 1,252 1,331 2,080 2,534 2,210 3,867 9,383 5,173 5,130 5,318
EBITDA(%) -62.0% -27.5% -417.6% -559.1% -159.2% -15.6% 149.4% -172.8% -99.1% -37.7% -15.8% -21.2% -46.0% 33.2% 36.1% 29.7% 30.5% 27.4% 35.4% 37.8% 28.1% 45.5% 58.4% 42.5% 39.1% 37.4%
Podatek (mln) -2 3 -22 -7 3 -84 179 -22 -30 2 -4 -2 -1 -336 289 428 589 434 880 109 313 297 1,250 520 246 367
Zysk Netto (mln) -23 -23 -76 -124 -107 42 -95 -102 -106 -83 -68 -104 -222 750 424 348 636 896 1,199 2,444 2,116 3,513 8,075 4,338 3,954 4,413
Zysk netto Δ r/r 0.0% 0.5% 228.1% 63.3% -13.6% -138.8% -328.9% 7.2% 3.2% -21.7% -18.0% 54.0% 112.3% -438.3% -43.4% -18.0% 82.7% 40.8% 33.8% 104.0% -13.4% 66.0% 129.9% -46.3% -8.9% 11.6%
Zysk netto (%) -67.0% -39.2% -346.7% -565.7% -186.9% 24.0% -144.2% -161.3% -84.5% -34.7% -17.9% -22.8% -49.7% 54.4% 20.2% 12.3% 15.5% 18.4% 20.4% 36.4% 26.9% 41.3% 50.2% 35.6% 30.1% 31.1%
EPS -0.74 -0.66 -1.81 -2.83 -2.13 0.75 -1.71 -1.77 -1.59 -1.05 -0.85 -1.26 -2.45 7.92 4.23 3.36 6.17 8.55 11.27 21.29 19.38 32.65 76.4 40.51 37.05 40.9
EPS (rozwodnione) -0.73 -0.66 -1.81 -2.83 -2.13 0.74 -1.71 -1.77 -1.59 -1.05 -0.85 -1.26 -2.45 6.75 3.72 2.98 5.52 7.7 10.34 21.29 18.46 30.52 71.97 38.22 34.77 38.34
Ilośc akcji (mln) 31 35 42 44 50 55 56 58 66 79 80 83 91 111 111 113 115 116 116 115 109 108 106 107 107 108
Ważona ilośc akcji (mln) 31 35 42 44 50 56 56 58 66 79 80 83 91 115 111 113 115 116 116 115 115 115 112 114 114 115
Waluta USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD